Long Ideas - Many biotechnology companies choose to focus on specific niches of the market that they deem to be the most lucrative. Gilead Sciences (NASDAQ:GILD) is making … Continue Reading
Read nowLong Ideas - Few diseases have a more pressing need for treatment than obesity. For well over a decade, there have been no new obesity drugs on the … Continue Reading
Read nowLong Ideas - Investors who choose to invest in speculative stocks often choose the biotechnology sector as their sector of choice. It’s easy to understand why; biotechnology companies … Continue Reading
Read nowLong Ideas - The biotechnology sector is no stranger to battleground stocks. Companies such as Dendreon (NASDAQ:DNDN) serve as solid examples of this fact. But perhaps no biotechnology … Continue Reading
Read nowLong Ideas - The biotechnology sector is one where growth is, for the most part, fueled by a single factor: new drugs. Companies that develop the next generation … Continue Reading
Read nowLong Ideas - The past few months have been eventful ones for Biogen Idec (NASDAQ:BIIB), as the company awaits the FDA’s decision on BG-12 and continues to build … Continue Reading
Read nowLong Ideas - When a biotechnology company is around 20 years after its incorporation, common wisdom would suggest that it has become a major player in the biotechnology … Continue Reading
Read now